N-butyl, N-methyl, 11-[3′,17′ β-(dihydroxy)-1′,3′,5′(10′)- estratrien-16′ α-yl]-9(R/S)-bromo undecanamide: synthesis and 17β-HSD inhibiting, estrogenic and antiestrogenic activities
- 30 September 1994
- Vol. 59 (9) , 536-547
- https://doi.org/10.1016/0039-128x(94)90072-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- 16α-propyl derivatives of estradiol as inhibitors of 17β-hydroxysteroid dehydrogenase type 1Bioorganic & Medicinal Chemistry Letters, 1994
- 11β-Amidoalkyl estradiols, a new series of pure antiestrogensThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Expression of human 17β-hydroxysteroid dehydrogenase in mammalian cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissuesThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Synthesis and biological activity of new halo-steroidal antiestrogensJournal of Medicinal Chemistry, 1991
- Therapeutic potential of pure antioestrogens in the treatment of breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Endocrine Pharmacology of Antiestrogens as Antitumor Agents*Endocrine Reviews, 1990
- Antiestrogenic properties of keoxifene,trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cellsBreast Cancer Research and Treatment, 1989
- Novel steroidal pure antiestrogensSteroids, 1989
- Mechanisms of oestrogen antagonism by nonsteroidal antioestrogensMolecular and Cellular Endocrinology, 1982